Search Results - "Rose, Emily K."

Addressing Advance Care Planning in Patients With COPD by Rose, Emily K., O’Connor, James

“…COPD is a progressive debilitating disease with diminished quality of life after hospital admissions. Because of the nature of the disease, it is important to…”
Get full text

A Unique Case of Valacyclovir Toxicity and Pseudobulbar Affect in a Patient On Peritoneal Dialysis by Memon, Waqas, Rose, Emily K, Akram, Ayesha, Simba, Brian

“…There are a few cases of valacyclovir-associated neurotoxicity (VAN) reported. This case report documents a case of a 55-year-old male presenting with…”
Get full text

Transition-Metal-Free Synthesis of a Densely Functionalized Benzodioxole Intermediate toward Lotiglipron by Wang, Jimmy, Clarke, James, Badland, Matthew, Broadbelt, Brian, Dow, Louise F., Fenton, Harriet A. M., Laity, Daniel A., Mathew, Jinu S., Rose, Emily K., Tamosiunaite, Neringa, Twiddle, Steven J. R., Walton, Robert

“…A decagram-scale preparation of the key intermediate (±)-2-(4-bromo-2-methylbenzo­[d]­[1,3]­dioxol-2-yl)-5-chloropyridine is described. Key steps involve a…”
Get full text

Development of the Synthetic Route to PF-06878031 Part 1: Selective Alkylation Route by Brea, Oriana, Buck, Julia, Carson, Nessa, Derrick, Andrew M., Fussell, Steven J., Gymer, Adam E. S., Hawksworth, Michael, Hopkins, Adam W., Ingram, Heather, Johnson, Rebecca A., Laity, Daniel A., Mathew, Jinu S., Moses, Ian B., Rellegue, James, Rose, Emily K., Twiddle, Steven J. R., West, Adam

“…The target compound PF-06878031 is a key structural fragment of a range of oral late-stage glucagon-like peptide-1 receptor agonists (GLP-1-RA) under…”
Get full text

Development of the Synthetic Route to PF-06878031 Part 2: Amide Reduction Route by Brown, Maria S., Buck, Julia, Critcher, Douglas J., Derrick, Andrew M., Fenton, Harriet, Fussell, Steven J., Gymer, Adam E. S., Hawksworth, Michael, Ingram, Heather, Johnson, Rebecca A., Kumar, Rajesh, Laity, Daniel A., Lewis, Russell D., Mathew, Jinu S., McGivern, Laura, Moses, Ian B., Palaia, Andrew T., Patel, Miheal J., Rellegue, James, Rose, Emily K., Scott, Adam, Steflik, Jeremy, Twiddle, Steven J. R.

“…The target compound PF-06878031 is a key structural fragment of a range of oral late-stage glucagon-like peptide-1 receptor agonists (GLP-1-RA) under…”
Get full text